In the early phase of TLS development in ovarian cancer (66), CXCL13-producing CD4 T cells were predominantly coincident with CD4 and CD8 T cells, and it transmigrated away from T cell zones to the CD21+ FDCs as TLS matured in ovarian cancer. The gene discussed is CR2; the disease is ovarian cancer.